Stage III Vulvar Cancer: Clinical Trials

3 trials for Stage III Vulvar Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Stage III Vulvar Cancer: new trials by email Literature Review of Stage III Vulvar Cancer trials Research Report on Stage III Vulvar Cancer

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
behavioral, psychological or informational intervention - Ovarian Sarcoma, Ovarian Stromal Cancer
Phase 2CompletedOhio State University Comprehensive Cancer Center1002010-10-012018-05-30
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies
stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma
Phase 2CompletedCase Comprehensive Cancer Center502009-05-012013-11-28
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
3-Dimensional Conformal Radiation Therapy, Cisplatin, Conventional Surgery - Stage III Vulvar Cancer, Stage IVB Vulvar Cancer
Phase 2CompletedGynecologic Oncology Group612005-01-012017-11-20

Narrower conditions

Vulvar Neoplasms (3)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Endometrial Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Vaginal Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Gestational Trophoblastic Disease (1)  ·  Neoplasms (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Neoplasms by Site (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Vulvar Diseases (3)  ·  Adnexal Diseases (2)  ·  Carcinoma (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Gonadal Disorders (2)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Platinum (1)  ·  Radiosurgery (1)  ·  Radiotherapy, Conformal (1)

Sponsors

Case Comprehensive Cancer Center (1)  ·  Gynecologic Oncology Group (1)  ·  Ohio State University Comprehensive Cancer Center (1)

Countries

United States (3)

Top investigators

David Moore (1)  ·  Kristen M. Carpenter, Ph.D (1)  ·  Robert DeBernardo, MD (1)

Results publications

PMID 40082377

NIH funding

R21CA149675 (1), U10CA027469 (1)